tm logo
FAYNUVAY
FORMALIZED

on 27 Dec 2023

Last Applicant/ Owned by

BOEHRINGER INGELHEIM INTERNATIONAL GMBH

55218 Ingelheim

DE

Serial Number

2302029 filed on 08th Sep 2023

FAYNUVAY

Trademark usage description

pharmaceutical preparations for the prevention and treatment of diseases and disorders of the alimentary tract and metabolism, namely, renal diseases, Read More

Classification Information


Class [005]
Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the alimentary tract and metabolism, namely, renal diseases, liver diseases, pancreas diseases, digestive system disorders, gastrointestinal diseases and disorder, obesity; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the blood and blood forming organs, namely, vascular diseases, hematology, blood disorders; pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and disorders, musculoskeletal diseases and disorders, central nervous system diseases and disorders, peripheral nervous system diseases and disorders; pharmaceutical preparations for the prevention and treatment of genitourinary system genitourinary diseases, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations for the prevention and treatment of respiratory system; pharmaceutical preparations for the prevention and treatment of dermatological diseases and disorders, damaged skin and tissues, namely, rashes, sores, psoriasis, eczema; pharmaceutical preparations for the prevention and treatment of inflammation and inflammatory diseases and disorders, namely, anti-inflammatories; pharmaceutical preparations for the prevention and treatment of ophthalmological diseases and disorders; pharmaceutical preparations for the treatment and prevention of hormonal diseases and disorders; pharmaceutical preparations for the treatment and prevention of infectious diseases and disorders and viral infections, namely, antibiotics, anti-infectives, antivirals; pharmaceutical preparations for the prevention and treatment of oncological diseases; pharmaceutical preparations for the prevention and treatment of auto-immune diseases and disorders; pharmaceutical preparations, namely, cell based immune therapeutic products for treatment of cancer; cell based immune therapeutic products being pharmaceutical preparations for treatment of immunological diseases, namely, autoimmune diseases and disorders; cell based immune therapeutic products being pharmaceutical preparations for treatment of infectious diseases, namely viral infections.


Classification kind code

12

Mark Details


Serial Number

2302029

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 256
on 28th Oct 2024
Notification of Possible Opposition Sent
Submitted for opposition 257
on 28th Dec 2023
Designation Notification - Madrid Protocol
Submitted for opposition 1
on 27th Dec 2023
Created
Submitted for opposition 31
on 27th Dec 2023
Formalized
Submitted for opposition 30
on 08th Sep 2023
Filed
Submitted for opposition 228
on 08th Sep 2023
International Registration